Search

everythinglearnresearchcommunity

for

Search:↓

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

lncRNA XLOC_008679 and gene KRT35 affect cashmere fineness in goats.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Non-immune factors play a significant role in alopecia areata.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The document concludes that more research is needed to fully understand the causes of PCOS.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Young women with PCOS without additional risk factors may have normal heart function.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.